Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: Although there was no discussion of costs, the article was clear in stating that vaccines arefor the most partin an early stage of development, so this omission is understandable. We wanted to seebetter coverage of the data here. The story leads with an anecdote about a patient who kicked a pack-a-day smoking habit after treatment with a nicotinevaccine in a study. And later,the story says that smokers who received thatvaccine were "about three times as likely to be off cigarettes 44 weeks after vaccination than subjects given a placebo."The story should have providedthe absolute rates of success reported in the study, which were only 16% for the treatment group compared with 6% for the placebo group, according to theheart.org. Elsewhere,the storydescribes an experimental anticocaine vaccine that was apparently very effective in a mouse study; it could have reported onphase II human data that is available for theTA-CDanticocaine vaccine that was also mentioned in the story. These data again suggest that only a minority of patientsmay benefit from the use of anti-addictionvaccines. The story states that "clinical trials have so far revealed no significant side effects" from vaccine treatments. However, we think the story should have included an important caveat: that these are early stagetrials involving small numbers of patients thatcan't provideconclusive evidence of safety. In addition, it should be recognized that addictions arechronic conditions and these vaccine treatments are likely to be long-term as well. Therefore, longer-term adverse effects should be expected, especially for a treatment that interferes with molecules closely related to the body's natural chemical messengers. The story could have been a bit more circumspect on this point. The promise of this new vaccine technology is counterbalanced by coverage of the uncertainties. The story gives appropriate weightto thedisappointing resultsreported in a number of early clinical studies, noting: "Failures have so far outnumbered successes." The story adds thateven in one of the successful vaccine studies, the benefitswere not as robust as those seen with a smoking cessation drug that is already on the market. There also is no prospect for a vaccine to treat alcoholism, according to the story. The article should have been more direct about the limitations of mouse research, and there was not enough detailon thedata publishedin the various studies reported on (a deficiency we address under the "Benefits" criterion). However, since the story was trying to present a broad overview of happenings in the field and wasn't attempting to summarize any particular study, we'll give the benefit of the doubt here and award a satisfactory. The story didn't exaggerate the effects ofsubstanceabusedisorders or otherwise engage in disease-mongering. The sourcing of this story was good. We hear fromacademics, government researchers, and industry executives. Their voices provide balance and give texture to the coverage. It should be noted, however, that most of these experts have a vested interest in the field or the success of a particular treatment, whether because of industry ties or because they are leading experiments ona particular approach. Even the government experts might be biased by their provision of significant financial support for research in this area. It would have been nice to heara comment about the vaccines from someonewho is certifiably free of all potential conflicts. But we can't justify docking pointssince there is no voice that is overly enthusiastic about the concept. The story compares the potential of vaccines with the benefits of existing medications for addictionand notes that theavailable drugs might work better. We would liketo haveseen more ink givento the role ofbehavioralapproaches in the management of addiction, which are supported by considerable evidence. However,the story does acknowledgethatvaccines "would likely be used alongside psychological therapy."We'll call it good enough for a satisfactory. The article helpfully states that "It could be years, if ever, before any vaccines to treat addiction reach the market." The article does a good job of describing how far along the various experimental vaccines mentioned in the article are in their development. Although the story could haveprovided more background on the history ofanti-addiction vaccines (aheroin vaccine was explored in the 1970s), the treatments being explored now are different fromanything currently available. So we don't think this story overstates thenoveltyof the research. This story is not based on a news release.

Output: Quest for Vaccines to Treat Addiction

Input: Consider Input: Ebola has left those living in the country's east weary and fearful, and, just as they were preparing to declare an end to the outbreak, a new case popped up. Now, they will now have to manage both threats at once. The new virus has overwhelmed some of the world's best hospital systems in Europe and ripped through communities in New York. In Congo, it could spread unchecked in a country that has endured decades of conflict, where corruption has left the the population largely impoverished despite mineral wealth, and where mistrust of authority is so entrenched that health workers have been killed during the Ebola outbreak. It's also unclear how forthcoming international support will be at a time when the whole world is battling the coronavirus. "It all feels like one big storm," said Martine Milonde, a Congolese community mobilizer who works with the aid group World Vision in Beni, which has been the epicenter of the Ebola outbreak. "Truly, this is a crisis within a crisis within a crisis. The community suffers from insecurity, and suffered under Ebola, and now may have to face COVID-19." In early March, an Ebola patient whom many hoped would be the last was discharged, and the outbreak was supposed to be officially declared over Sunday. But the World Health Organization on Friday announced a new case in Beni. The outbreak has claimed more than 2,260 lives since August 2018 the second largest the world has ever seen, after the 2014-2016 outbreak in West Africa. Still, there is some hope: Many of the tools used to fight Ebola hand-washing and social distancing chief among them are also key to combating the coronavirus. In Beni, which has reported two cases of the new coronavirus, "the communities here hold onto some hope that they are going to overcome this pandemic the way they had been working to overcome Ebola," said Milonde. "They are counting on the caution, vigilance and hygiene practices that they have been performing to save their families." Community advocates in Beni who walk around with megaphones to talk about Ebola have started to include warnings about the coronavirus. Messages explaining COVID-19, the disease caused by the virus, and where to go if sick are being spread on radio stations, through text message blasts and by religious leaders. Schools, churches and mosques are already armed with hand-washing kits. Beni's mayor, Nyonyi Bwanakawa, says many of the measures will be familiar but the recommendations to stay home are more stringent than what is required for Ebola, and officials are prepared to take "dramatic measures" if people resist. Unlike Ebola, which kills about half of the people it infects, the new coronavirus causes mostly mild or moderate symptoms in about 80% of people. Spreading Ebola typically requires an exchange of bodily fluids, and people have often been infected when caring for loved ones or mourning in traditional funerals that involve close contact with the body. In contrast, the new coronavirus is far more contagious and mostly spread by people coughing or sneezing, including those with only mild flu-like symptoms. That means the task of controlling the virus' spread in Congo will be massive: The government has only limited control in parts of the vast country, there are also some dense population centers with poor sanitation and infrastructure, and the country's mineral-rich east is beset by violence from various armed groups. Dr. Michel Yao, program manager for emergency response at the WHO's Africa office, said implementing robust testing and contact tracing will be key. But getting the community fully involved in fighting the disease might be even more important. That means not just speaking at communities, "but giving them responsibility and roles to play." Initially, efforts to control Ebola were met with resistance, one of the major contributors to its spread. Amid the insecurity in the country's east, superstitions arose, and some clinics to treat Ebola patients were attacked and health workers killed. The capital, Kinshasa, a tightly packed city of 14 million located on the country's western border, remains another major worry, said Yao, who is based at WHO's African headquarters in the neighboring Republic of Congo. "If it reaches this place, it would be a big disaster," he said. "Africa is only partly ready," said Yao. "If we stick to sporadic cases, this can be managed." But many more developed countries have seen cases surge, and a sizable outbreak in Congo could easily overwhelm its hospital system. Advanced equipment to deal with severe respiratory illness, which the coronavirus can cause, is lacking: The Health Ministry says there are about 65 ventilators all in Kinshasa and 20 more on order for a country of more than 80 million people. There have been 215 confirmed cases of the new coronavirus in Congo, with 20 deaths, the ministry said Friday. And health workers will also need to find a way to continue to treat people infected with the many other diseases that regularly torment the population. Over the past year, for instance, a measles outbreak killed more than 6,000 people in Congo. In addition, because donor countries are themselves dealing with outbreaks, help from abroad could be less forthcoming. The key, Yao said, is training more people locally to care for the ill. The challenge will be rallying again after many months of trying to contain Ebola. "The job wasn't yet finished, and we have to deal with another emergency," Yao said. Katungo Methya, 53, who volunteers for the Red Cross in Beni, expressed a weariness many feel. "It's so upsetting to have this second disease. We lost so many people through Ebola, a lot of deaths, now corona," she said. "Everyone is really afraid." ___ Petesch reported from Dakar, Senegal. AP medical writer Maria Cheng in London contributed from London.

Output: Congo, weary from Ebola, must also battle the coronavirus.

Input: Consider Input: Nearly 1,500 places to stay have been made available under the scheme amid a slump in bookings on the home rental start-up as travel restrictions and curbs on social gatherings come into force around the world. Britain has looked to bolster its public health service to deal with the crisis, including establishing a field hospital in a one-time Olympic venue and turning a theme park into a testing facility for health workers. "By working together, we can ensure that frontline workers can find a free and convenient place to stay as they continue their critical work," said Patrick Robinson, Director of Public Policy at Airbnb. Airbnb has done similar schemes in Italy and France in response to the outbreak, and aims to house 100,000 emergency personnel around the world during the epidemic. The company has suspended marketing activities to save money, and executives are taking a pay cut as the firm battles with a downturn in bookings triggered by the spread of coronavirus. Airbnb's bookings in major cities across the world have suffered as travelers cancel trips and stay at home to protect themselves and prevent the spread of coronavirus.
Output: Airbnb hosts to provide free rooms for British health workers.